China approves Sinopharm vaccine | Sunday Observer

China approves Sinopharm vaccine

1 January, 2021

The Covid-19 vaccine developed by China –owned drug maker, Sinopharm was granted conditional approval for the Chinese general public.

The pandemic emerged in the city of Wuhan, China in December 2019, however, China has now managed to bring the virus infection rate down to very low.

The United Arab Emirates (UAE) and Bahrain have already approved emergency use of the Sinopharm vaccine.